RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
about
Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast CancerMolecular interaction of a kinase inhibitor midostaurin with anticancer drug targets, S100A8 and EGFR: transcriptional profiling and molecular docking study for kidney cancer therapeuticsThe multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic diseaseS100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transitionCytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis.RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironmentS100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.S100 proteins in cancer.MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.Cyclin D3 predicts disease-free survival in breast cancerS100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.S100A8/A9 is associated with estrogen receptor loss in breast cancer.Dephosphorylated cofilin expression is associated with poor prognosis in cases of human breast cancer: a tissue microarray analysis.MiR-507 inhibits the migration and invasion of human breastcancer cells through Flt-1 suppression.The role of S100 proteins and their receptor RAGE in pancreatic cancer.Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer.Ranking, selecting, and prioritising genes with desirability functions.The tumor microenvironment and inflammatory breast cancer.S100A8+ stroma cells predict a good prognosis and inhibit aggressiveness in colorectal carcinoma.AGER promotes proliferation and migration in cervical cancer.Antitumor and anti-metastatic mechanisms of Rhizoma paridis saponins in Lewis mice.A Systems Biology Approach Provides Deeper Insights into Differentially Expressed Genes in Taxane-Anthracycline Chemoresistant and Non-Resistant Breast CancersQuantitative mass spectrometry analysis reveals a panel of nine proteins as diagnostic markers for colon adenocarcinomas.
P2860
Q27342714-FCDE9FA4-21F4-4015-8821-1B619D6468C1Q28544659-872C21BC-6BE4-44A5-98D5-73065AF9859CQ28830568-11D97608-60A9-446A-BF26-9E8383B6EBB8Q33648719-023EB804-6B21-4489-82E9-1C207F79121EQ33873665-8AB7906D-4769-4E98-A78C-D7C50EE624E1Q34457327-21BAA8B6-3430-4F42-A4FD-AA44BE053371Q35055025-64D37134-B850-4314-8C0D-620455728C9CQ35170154-56897137-E832-4F7F-90CB-F4003F08B47BQ35206368-32618D0B-2CDA-423D-8BCE-A2FD4B39E5EAQ36010284-3733CA01-0320-412B-A2BC-50D42AFF0CBCQ36094615-BB022147-644B-4512-B0D6-5A97D20D325BQ36287418-8245ECD5-BBB5-47F4-87C3-E7930778D138Q36640358-09C5E48D-669D-4832-90AA-5C199EAFA1E7Q37361986-A768813A-9051-4B06-8B14-B1507D322C8AQ37392824-A68F925F-B25B-402A-8D57-31605224CD0DQ38598852-5FCBAEF1-EECD-42B8-A7DB-B36E33DB9381Q38743691-061064CA-8663-4F4C-91B0-6D824D040892Q38951812-D2D2C750-B9A0-4CE7-AFA7-FBB6A97B3A75Q38966467-DACC77C6-FE30-4793-8037-775416674091Q40127796-5860772D-BF5A-4CDA-B131-935F1FBDB8A2Q40234584-23EC134C-E4E3-453D-9E9C-831384C9BB3AQ41396244-AD168DB6-4809-4C61-B271-724B2EB9DFE4Q45510446-3A22AF67-2452-490C-BF22-E00F3C24F991Q47234398-D7B4BA15-35B4-4F96-94BC-51BE21F7E45DQ47338794-758B6B6F-83DC-49BA-A153-60DD795F9B51Q47601795-9ABA5281-3CD5-4D12-B4C0-8A31245D4E11Q55026142-1F5E1A6D-0D6B-4B9C-957B-A41C3D8DBEB8
P2860
RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
RAGE-binding S100A8/A9 promote ...... helial-mesenchymal transition.
@en
RAGE-binding S100A8/A9 promote ...... helial-mesenchymal transition.
@nl
type
label
RAGE-binding S100A8/A9 promote ...... helial-mesenchymal transition.
@en
RAGE-binding S100A8/A9 promote ...... helial-mesenchymal transition.
@nl
prefLabel
RAGE-binding S100A8/A9 promote ...... helial-mesenchymal transition.
@en
RAGE-binding S100A8/A9 promote ...... helial-mesenchymal transition.
@nl
P2093
P2860
P1476
RAGE-binding S100A8/A9 promote ...... helial-mesenchymal transition.
@en
P2093
Baogang Zhang
Chonggao Yin
Weiyi Chen
Xiaolong Li
Yueliang Qi
Yuqing Liu
P2860
P2888
P304
P356
10.1007/S10549-013-2737-1
P407
P577
2013-11-01T00:00:00Z